Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)

BACKGROUND: A better understanding of the factors that contribute to heterogeneous outcomes and lifetime disease burden in hypertrophic cardiomyopathy (HCM) is critically needed to improve patient management and outcomes. The SHaRe registry (Sarcomeric Human Cardiomyopathy Registry) was established...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circulation
Main Authors: Ho, Carolyn Y., Day, Sharlene M., Ashley, Euan A., Michels, Michelle, Pereira, Alexandre C., Jacoby, Daniel, Cirino, Allison L., Fox, Jonathan C., Lakdawala, Neal K., Ware, James S., Caleshu, Colleen A., Helms, Adam S., Colan, Steven D., Girolami, Francesca, Cecchi, Franco, Seidman, Christine E., Sajeev, Gautam, Signorovitch, James, Green, Eric M., Olivotto, Iacopo
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2018
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6170149/
https://ncbi.nlm.nih.gov/pubmed/30297972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.117.033200
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados